Freshfields leads Moderna to win in German court but pharma company is not so successful in the US | 1yr
Pharmaceutical/Medical - Page 3
Sarah Gagan will team up with New York-based Amir Ghavi who joined from Fried Frank earlier this month | 1yr
US firm snaps up team with expertise in life sciences and technology space | 1yr
Leading alternative legal services provider makes third acquisition in nine months | 1yr
This second edition offers updated guidance on protecting brands against counterfeiting and the grey market, covering relevant legislation, enforcement measures and cross-border strategies in key jurisdictions around the world. | 1yr
Highly-regarded trial lawyer Allison Brown joins with four more partners | 1yr
Cravath advises longtime client J&J as it boosts key neurological drugs division | 1yr
Joiners arrive from Hausfeld, Pinsent Masons and Gowling WLG | 1yr
Patent litigator Alexander Ritter marks latest in string of European hires by the US firm | 1yr
Group led by partners Tom Meyers and Zachary Hyde joins across Boston and New York | 1yr
Firm says hire underscores commitment to strengthening UK IP practice | 1yr
Luke Tucker Harrison’s prognosis is good, following successful treatment | 1yr
Merged firm to house 230 professionals and operate under Venner Shipley name | 1yr
Healthcare deals specialist Jason Zemmel will be based in London | 1yr
The long-running IP dispute related to the Nobel Prize-winning gene editing technology CRISPR rumbles on and now extends beyond ownership, write HSF lawyers Emily Bottle and Dylan Churchill | 1yr
Plaintiff lawyer David Kessler was lead counsel in landmark Tyco class action | 1yr
Sale to US private equity firm Clayton Dubilier & Rice comes as investors anticipate more and larger European PE buyouts | 1yr
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 1yr
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 1yr
Arrival of Tim Powell continues US firm’s European IP push | 1yr
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 1yr